Tirzepatide Trial to Assess Efficacy, Safety for Obesity in Type 1 Diabetes Patients on MiniMed 780G
Tirzepatide for Excess Weight in Adults With Type 1 Diabetes Using MiniMed 780G.
Abstract
A new clinical trial will evaluate tirzepatide's efficacy and safety for managing excess weight in adults with Type 1 Diabetes using MiniMed 780G, addressing a critical unmet need.